Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
California Seeks Paramount Divestitures in Warner Bros. Merger 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Trump Buys SpaceX Shares After Record IPO 
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
KPMG Australia Cuts 5% of Workforce Amid Scandal 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
Add as a preferred source on Google
NEW YORK, May 01, 2018 -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it will be presenting at the 3rd annual Disruptive Growth & Healthcare Conference in New York City on Tuesday, May 8th at 1:45 PM, Eastern Time. Chief Executive Officer of NanoVibronix, Brian Murphy, will be presenting, as well as meeting with investors. Mr. Murphy will also be presenting on the Disruptive Pain Management Panel at 3:00 PM on May 8th.
The 2018 Disruptive Growth & Healthcare Conference will offer investors the opportunity to discover life science companies focusing on solutions for unmet medical needs and growth companies with disruptive technologies and business models.
About NanoVibronix
NanoVibronix Inc. (NASDAQ:NAOV) is a medical device company headquartered in Elmsford, NY with research and development in Nesher, Israel, that is focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave technology. The company's technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including the disruption of biofilms and bacteria colonization, as well as providing pain relief. The devices can be administered at home, without the assistance of medical professionals. The company's primary products include PainShield®, UroShield™ and WoundShield™. Additional information about the company is available at: www.nanovibronix.com.
About RHK Capital:
Advisory Group Equity Services, Ltd. (dba RHK Capital) was founded in 1984. RHK Capital is a boutique investment banking firm specializing in small to medium-sized transactions. RHK is led by a management team with extensive financial industry experience and a desire to provide companies and individuals with the tools and expertise to accomplish their financial goals. In addition to investment banking, RHK has grown to include businesses in general securities, emerging market securities, distressed and high yield debt securities, investment management, mortgages, and business lending. As a division of Advisory Group Equity Services (AGES), all securities are offered through Advisory Group Equity Services Ltd., a registered broker-dealer, member of the Financial Industry Regulatory Authority and the Securities Investor Protection Corporation.
Investor Contacts:
Crescendo Communications
[email protected]
(212) 671-1021
